1. Isolated limb perfusion with the tumor‐targeting human monoclonal antibody–cytokine fusion protein L19‐TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma1. Issue 2 (4th June 2012) Authors: Papadia, Francesco; Basso, Valeria; Patuzzo, Roberto; Maurichi, Andrea; Di Florio, Annabella; Zardi, Luciano; Ventura, Elisa; González‐Iglesias, Reinerio; Lovato, Valeria; Giovannoni, Leonardo; Tasciotti, Annaelisa; Neri, Dario; Santinami, Mario; Menssen, Hans D.; De Cian, Franco Journal: Journal of surgical oncology Issue: Volume 107:Issue 2(2013:Feb. 01) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2‐Arm, Crossover, Randomized, Open‐Label Study in Healthy Volunteers. Issue 3 (30th July 2018) Authors: Menssen, Hans D.; Quinlan, Michelle; Kemp, Charisse; Tian, Xianbin Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 3(2019) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗